QIAGEN and British Veterinary Laboratories Agency Expand Partnership in Veterinary Testing
November 4, 2009
New Agreement Covers Widespread Bacterial Infections in Horses VENLO, Netherlands--QIAGEN (NASDAQ:QGEN) (FWB:QIA) today announced an expansion of its strategic partnership with the United Kingdom’s Veterinary Laboratories Agency (VLA), one of the world’s leading research institutions in veterinary science. Under the terms of the agreement, QIAGEN has received the exclusive rights to commercialize three new PCR-based [...]
November 4, 2009
CARLSBAD, Calif. -- GenVault Corporation (Carlsbad, CA) today announces that William Brody, M.D., Ph.D., has joined its Board of Directors. Dr. Brody, the Irwin Jacobs Presidential Chair of the Salk Institute, is an acclaimed physician-scientist and university leader. Prior to joining the Salk Institute, Dr. Brody served as president of The Johns Hopkins University. He [...]
Link Technologies Inks First License to RiboTask’s Unlocked Nucleic Acid (UNA) Monomers
November 3, 2009
BELLSHILL, SCOTLAND: The ISO 9001:2000 certified specialist oligonucleotide reagent manufacturer, Link Technologies Ltd, is pleased to announce the commercialisation and launch of a range of unlocked-nucleic acid (UNA) monomers under license from RiboTask ApS, Denmark. Under the terms of the agreement Link are permitted to sell the four UNA monomer phosphoramidite reagents for use in [...]
FEI Sells Phenom(TM) Product Line
November 3, 2009
HILLSBORO, Ore. -- FEI Company (Nasdaq:FEIC - News) announced that Phenom-World, a majority-owned subsidiary of NTS Group B.V. (NTS) of Eindhoven, The Netherlands, has acquired FEI's Phenom(TM) product line. NTS has been FEI's manufacturing partner and was closely involved with the development of the innovative desktop scanning electron microscope before it was introduced in 2007. [...]
Sigma-Aldrich Signs License Agreement With Polyplus-transfection
November 3, 2009
Commercialization of ZNA technology provides solutions for increased affinity for nucleic acids ST. LOUIS -- Sigma-Aldrich (Nasdaq: SIAL - News) today announced a worldwide licensing agreement with Polyplus-transfection (Strasbourg, France) to manufacture and commercialize Zip Nucleic Acid (ZNA(TM)*) oligonucleotides, a new technology that provides solutions for increased affinity for nucleic acids. Under the terms of [...]
Cerno Bioscience, Agilent Technologies to Co-Market MassWorks for GC/MSD
November 3, 2009
Calibration Software Enables Single Quadrupole Instruments to Easily Identify Unknowns Cerno Bioscience and Agilent Technologies Inc. (NYSE: A) today announced they will jointly market Cerno's MassWorks calibration software to Agilent GC/MSD ChemStation users. This novel calibration increases the mass accuracy of Agilent's single quadrupole GC/MSD sufficiently to identify unknown compounds. This normally requires use of [...]
Accelrys to Showcase Materials Studio 5.0 at AIChE 2009
November 3, 2009
Conference Includes Presentations From Boeing and U.S. Army Research Laboratory SAN DIEGO, CA -- Accelrys, Inc. (NASDAQ:ACCL - News), a leading provider of scientific business intelligence software and services, will participate in the AIChE (American Institute of Chemical Engineers) Annual Meeting being held at the Gaylord Opryland Hotel in Nashville, Tennessee from November 8 to [...]
Roche NimbleGen Arrays Help Unveil the Secrets of Insidious Potato Blight
November 3, 2009
MADISON, Wis. -- A large international team of researchers recently published the 240-megabase DNA sequence of Phytophthora infestans, a robust parasitic water mold responsible for the Irish potato famine of the 1840s, in Nature (1). Breeders have not been able to produce potato cultivars that remain resistant to this insidious blight, aptly named as the [...]
PerkinElmer Secures FDA 510K Clearance for Newborn Screening Platform
November 3, 2009
Automated GSP™ Genetic Screening Processor enables multi-analyte analysis, accelerates sample screening and increases accuracy WALTHAM, Mass. -- PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that the Company has received 510K clearance from the U.S. Food and Drug Administration for its GSP™ Genetic Screening Processor, [...]
NTS Group takes the lead in Phenom-World
November 3, 2009
FEI Company retains a minority stake in this new BV (limited company) Eindhoven -- The NTS Group has announced its majority participation in Phenom-World BV, a new limited company founded on November,3 to realise the marketing, sales and service of Phenom. FEI Company, which has so far been responsible for the marketing and sales of [...]
